# Cognitive function is associated with the progression of non-tremor motor symptoms in Parkinson’s disease

**Authors:** Melissa C. Gibbs, Aminette D’Souza, Charalampos Sotirakis, Trevor J. Crawford, Chrystalina A. Antoniades

PMC · DOI: 10.3389/fnagi.2026.1765860 · Frontiers in Aging Neuroscience · 2026-02-12

## TL;DR

Lower cognitive function in Parkinson’s disease is linked to faster worsening of non-tremor motor symptoms over time.

## Contribution

This study shows that cognitive decline specifically predicts the progression of non-tremor motor symptoms in Parkinson’s disease.

## Key findings

- Lower MoCA scores were associated with steeper progression of non-tremor motor symptoms.
- Global cognition at baseline predicted motor impairment progression, but not initial severity.
- Tremor symptoms did not show a significant link to cognitive function progression.

## Abstract

Parkinson’s disease (PD) is characterized by motor impairment which consists of tremor and non-tremor symptoms. Cognitive function may overlap with specific aspects of voluntary movement and action initiation. This study aims to investigate associations between global cognition and the severity and longitudinal progression of tremor and non-tremor motor symptoms in PD.

As part of the Oxford Quantification in Parkinsonism (OxQUIP) study, 84 participants with PD were tested over seven visits at three-month intervals. At each visit, participants completed standardized global cognitive (MoCA) and motor (MDS-UPDRS-III) assessments. Tremor and non-tremor motor subscores were derived from corresponding MDS-UPDRS-III items. Linear mixed-effects models were calculated to analyze the effect of global cognition at baseline on the progression of (i) overall motor impairment, (ii) non-tremor motor symptoms, and (iii) tremor symptoms.

We did not find an association between MoCA scores and MDS-UPDRS-III severity, but there was a significant interaction between global cognition and the progression of motor impairment (p = 0.005). Lower MoCA scores were linked with steeper progression of non-tremor motor symptoms (p < 0.001), but not tremor symptoms (p = 0.380).

Global cognition at baseline is associated with the progression, but not severity, of motor impairment in PD; this finding is specific to non-tremor and not tremor motor symptoms. While both motor subdomains are known to be linked with dysfunction of sub-cortical circuits, non-tremor symptoms may also be influenced by disrupted cognitive inputs. Our results highlight the potential value of incorporating cognitive tools to complement motor examination in PD assessment.

## Linked entities

- **Diseases:** Parkinson’s disease (MONDO:0005180)

## Full-text entities

- **Genes:** SNCA (synuclein alpha) [NCBI Gene 6622] {aka NACP, PARK1, PARK4, PD1}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}
- **Diseases:** dementia (MESH:D003704), executive dysfunction (MESH:D006331), Parkinsonism (MESH:D010302), Gait impairments (MESH:D020234), Cognitive dysfunction (MESH:D003072), Movement Disorders (MESH:D009069), motor (MESH:D000068079), PSP (MESH:D013494), rigidity (MESH:D009127), frontal executive dysfunction (MESH:D001927), Tremor (MESH:D014202), akinetic (MESH:D018476), postural abnormalities (MESH:D054972), attentional and (MESH:D001289), gait disturbances (MESH:D020233), deficits (MESH:D009461), PD (MESH:D010300), neurodegenerative disease (MESH:D019636), AD (MESH:D000544)
- **Chemicals:** dopaminergic medication (-), Opicapone (MESH:C549349), Levodopa (MESH:D007980)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12935966/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12935966/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC12935966/full.md

---
Source: https://tomesphere.com/paper/PMC12935966